Flexion Therapeutics, Inc. Income Statement 2011-2024 | FLXN

Annual Income Statement Flexion Therapeutics, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	521 M	665 M	537 M	768 M	473 M	333 M	286 M	-	-	-
Shares	42.8 M	38.1 M	37.8 M	33 M	25.3 M	21.5 M	13.9 M	-	-	-
Net Income	-114 M	-150 M	-170 M	-137 M	-71.9 M	-46.3 M	-27.3 M	-18.2 M	-15 M	-11.4 M
Revenue	85.6 M	73 M	22.5 M	355 K	-	-	-	-	-	-
EBITDA	-89.7 M	-134 M	-157 M	-128 M	-68.6 M	-45.8 M	-26.9 M	-17.7 M	-14.9 M	-11.3 M
Operating Expenses	159 M	199 M	174 M	130 M	69.8 M	46.1 M	27 M	-	-	-
General and Administrative Expenses	105 M	130 M	121 M	78.8 M	28.5 M	13.4 M	9.06 M	6.7 M	3.95 M	3.05 M

All numbers in USD currency